Narayana Hrudayalaya (NH) | Financial Analysis & Statements
Narayana Hrudayalaya Ltd. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
15.1B
Gross Profit
9.6B
63.51%
Operating Income
2.5B
16.76%
Net Income
2.0B
13.05%
EPS (Diluted)
₹9.68
Balance Sheet Metrics
Total Assets
72.7B
Total Liabilities
36.4B
Shareholders Equity
36.3B
Debt to Equity
1.00
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Narayana Hrudayalaya Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 54.6B | 50.0B | 44.9B | 36.4B | 25.6B |
| Cost of Goods Sold | 26.9B | 25.3B | 23.3B | 20.2B | 15.6B |
| Gross Profit | 27.7B | 24.7B | 21.6B | 16.2B | 10.0B |
| Gross Margin % | 50.8% | 49.4% | 48.0% | 44.5% | 39.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.7B | 3.0B | 2.7B | 1.9B | 1.6B |
| Other Operating Expenses | 214.0M | -105.9M | 347.0M | 266.7M | 92.0M |
| Total Operating Expenses | 3.9B | 2.9B | 3.1B | 2.1B | 1.7B |
| Operating Income | 10.3B | 9.4B | 7.9B | 5.0B | 228.3M |
| Operating Margin % | 18.8% | 18.8% | 17.6% | 13.9% | 0.9% |
| Non-Operating Items | |||||
| Interest Income | 503.8M | 363.3M | 151.7M | 78.7M | 130.7M |
| Interest Expense | 1.5B | 968.8M | 690.8M | 655.7M | 754.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 9.4B | 8.9B | 7.5B | 4.3B | -560.7M |
| Income Tax | 1.5B | 989.0M | 1.5B | 876.6M | -417.7M |
| Effective Tax Rate % | 15.6% | 11.1% | 19.3% | 20.4% | 0.0% |
| Net Income | 7.9B | 7.9B | 6.1B | 3.4B | -142.9M |
| Net Margin % | 14.5% | 15.8% | 13.5% | 9.4% | -0.6% |
| Key Metrics | |||||
| EBITDA | 13.6B | 12.3B | 10.4B | 6.9B | 2.1B |
| EPS (Basic) | ₹38.90 | ₹38.86 | ₹29.85 | ₹16.85 | ₹-0.70 |
| EPS (Diluted) | ₹38.90 | ₹38.86 | ₹29.85 | ₹16.84 | ₹-0.70 |
| Basic Shares Outstanding | 203099835 | 203099835 | 203069835 | 202955918 | 202916718 |
| Diluted Shares Outstanding | 203099835 | 203099835 | 203069835 | 202955918 | 202916718 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Narayana Hrudayalaya Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 4.6B | 2.6B | 1.5B | 1.6B | 1.1B |
| Short-term Investments | 11.5B | 9.9B | 5.0B | 1.4B | 1.3B |
| Accounts Receivable | 5.6B | 4.2B | 4.3B | 4.4B | 2.8B |
| Inventory | 1.1B | 1.1B | 715.7M | 593.8M | 478.4M |
| Other Current Assets | 12.3M | 11.5M | 30.4M | 11.7M | 11.3M |
| Total Current Assets | 25.5B | 19.5B | 12.9B | 9.1B | 6.7B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 21.6B | 17.4B | 15.1B | 13.6B | 12.7B |
| Goodwill | 3.6B | 3.7B | 4.0B | 1.7B | 1.8B |
| Intangible Assets | 1.3B | 1.4B | 1.7B | 546.9M | 657.1M |
| Long-term Investments | 9.9M | 25.1M | 38.2M | 0 | - |
| Other Non-Current Assets | 981.0M | 1.7M | 893.6M | 634.4M | 311.2M |
| Total Non-Current Assets | 47.2B | 36.8B | 28.7B | 22.2B | 21.0B |
| Total Assets | 72.7B | 56.2B | 41.6B | 31.3B | 27.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.7B | 6.0B | 6.2B | 4.5B | 4.1B |
| Short-term Debt | 2.9B | 2.8B | 1.7B | 1.6B | 1.5B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 52.7M | 25.5M | 39.0M | 18.1M | 21.6M |
| Total Current Liabilities | 11.9B | 11.1B | 9.9B | 7.8B | 7.0B |
| Non-Current Liabilities | |||||
| Long-term Debt | 21.4B | 13.4B | 7.2B | 5.7B | 6.7B |
| Deferred Tax Liabilities | 636.2M | 470.6M | 869.8M | 509.5M | 130.3M |
| Other Non-Current Liabilities | 4.9M | 5.2M | 4.5M | 5.0M | 5.3M |
| Total Non-Current Liabilities | 24.4B | 16.3B | 10.4B | 8.6B | 9.5B |
| Total Liabilities | 36.4B | 27.4B | 20.3B | 16.4B | 16.5B |
| Equity | |||||
| Common Stock | 2.0B | 2.0B | 2.0B | 2.0B | 2.0B |
| Retained Earnings | 27.5B | 20.4B | 13.0B | 7.1B | 3.7B |
| Treasury Stock | 12.6M | 12.6M | 12.9M | 14.0M | 14.2M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 36.3B | 28.9B | 21.3B | 14.9B | 11.2B |
| Key Metrics | |||||
| Total Debt | 24.3B | 16.3B | 8.8B | 7.2B | 8.3B |
| Working Capital | 13.6B | 8.4B | 3.1B | 1.3B | -381.1M |
Balance Sheet Composition
Narayana Hrudayalaya Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 7.9B | 7.9B | 6.1B | 3.4B | -142.9M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | 0 | 2.6M | 6.0M |
| Working Capital Changes | -2.4B | -94.1M | -339.1M | -2.1B | -54.9M |
| Operating Cash Flow | 6.7B | 8.5B | 6.1B | 1.8B | 390.0M |
| Investing Activities | |||||
| Capital Expenditures | -10.8B | -9.7B | -5.2B | -2.5B | -697.5M |
| Acquisitions | - | 0 | -2.4B | 31.5M | 0 |
| Investment Purchases | -26.8B | -15.6B | -6.8B | -698.6M | -577.5M |
| Investment Sales | 24.2B | 9.3B | 1.9B | 300.3M | 64.1M |
| Investing Cash Flow | -13.4B | -14.8B | -11.8B | -2.7B | -1.2B |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -812.4M | -507.7M | -203.0M | - | - |
| Debt Issuance | 10.1B | 8.2B | 2.8B | 667.0M | 115.5M |
| Debt Repayment | -2.2B | -1.5B | -683.4M | -1.3B | -1.1B |
| Financing Cash Flow | 7.1B | 6.2B | 1.9B | -679.0M | -1.0B |
| Free Cash Flow | -961.8M | 959.9M | 5.6B | 2.3B | 2.3B |
| Net Change in Cash | 369.0M | -123.2M | -3.8B | -1.6B | -1.8B |
Cash Flow Trend
Narayana Hrudayalaya Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
46.80
Forward P/E
31.86
Price to Book
8.99
Price to Sales
5.39
PEG Ratio
-1.36
Profitability Ratios
Profit Margin
11.49%
Operating Margin
11.39%
Return on Equity
21.78%
Return on Assets
10.88%
Financial Health
Current Ratio
2.15
Debt to Equity
57.61
Beta
0.11
Per Share Data
EPS (TTM)
₹38.40
Book Value per Share
₹199.87
Revenue per Share
₹333.65
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| NH | 365.2B | 46.80 | 8.99 | 21.78% | 11.49% | 57.61 |
| Apollo Hospitals | 1.1T | 61.08 | 12.11 | 16.71% | 7.44% | 83.61 |
| Max Healthcare | 979.8B | 68.81 | 9.77 | 11.47% | 17.43% | 32.58 |
| Fortis Healthcare | 699.7B | 72.46 | 7.40 | 8.44% | 10.94% | 32.96 |
| Aster DM Healthcare | 364.6B | 110.37 | 8.03 | 147.28% | 7.33% | 43.79 |
| Global Health | 298.6B | 58.23 | 8.08 | 14.21% | 12.29% | 25.47 |
Financial data is updated regularly. All figures are in the company's reporting currency.





